Biophytis announces its participation in several conferences in Europe and the US during the first quarter of 2024

Biophytis management will be in San Francisco for meetings with potential partners and investors at the 42nd JP Morgan Healthcare Conference, to be held from 8 to 11 January 2024.

In addition, the company will be present:

  • at the Invest Securities Biomed Event on 30 January 2024 in Paris,
  • and at the BIO-Europe Spring conference from 18 to 20 March 2024 in Barcelona.

The JP Morgan Healthcare Conference is the world’s largest healthcare investment event, bringing together the world’s leading healthcare companies, biotechs and innovative technology developers with members of the international financial community.

Invest Securities’ Biomed Event is an annual forum dedicated to the healthcare sector, bringing together biotechs or medtechs, pharmaceutical companies and institutional investors in one-to-one formats.

BIO-Europe Spring is the top event dedicated to partnerships in the life sciences, bringing together more than 3,700 participants, including over 2,000 companies, and connecting the global biopharmaceutical community through thousands of meetings.